Miami Lakes

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Narcolepsy2 trials
• Insomnia1 trial

Phase

• Phase 36 trials

Status

• Completed4 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Axsome Therapeutics, Inc.6 trials

Running trials

• Recruiting

  Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

  NCT06568367· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Insomnia1 recruiting

Closed trials

• Terminated

  An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

  NCT06736509· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

  NCT05557409· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

  NCT05113745· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

  NCT05059223· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

  NCT04947553· Phase 3· Axsome Therapeutics, Inc.· Source